Sotio Biotech
SOTIO is a biotechnology company developing a new immunotherapy based on activated dendritic cells for the treatment of cancer.
Sotio Biotech has raised €280M across 1 funding round from 1 investor, most recently a round in Dec 2021. Based in Prague, Czech Republic; active in Healthtech. Data as of 28 Oct 2026.
Prague, Czech Republicwww.sotio.com ↗
Total raised
€280M
€280,000,000
Funding rounds
1
Investors
1
distinct backers
Active since
2021-12
latest 2021-12
Funding by year
EUR raised per yearSotio Biotech — funding by year — interactive chart.
Data table
| Sotio Biotech — funding by year | |
|---|---|
| 2021 | €280M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-12-02 | Other | €280M | PPF Group | View deal → |
Investors
1Related news
- Sotio Biotech Raises €280M in Fundingfinsmes.com · 2021-12
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Oura Health€779MFinland · Healthtech
Global coverage: FundingData